Data / Form D filings / NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd.: Form D filings
NeuroSense Therapeutics Ltd., a biotechnology company in Herzliya, Israel, filed 3 Form D notices with the SEC between 2023 and 2024. The latest, on December 12, 2024, reports $5 million sold of a $5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11 HAMENOFIM STREET, BUILDING B, Herzliya, Israel, 46725
- Phone
- +972-9-7996183
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1875091
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | New notice | $5,000,000 | $5,000,000 | 2 | Dec 5, 2024 | sec.gov | |
| Apr 25, 2024 | New notice | $4,470,000 | $4,470,000 | 1 | Apr 15, 2024 | sec.gov | |
| Jul 5, 2023 | New notice | $4,500,000 | $4,500,000 | 1 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cary Claiborne | Director | |
| Mark Leuchtenberger | Director | |
| Niva Russek-Blum | Executive Officer | |
| Christine Pelizzari | Director | |
| Revital Mandil-Levin | Director | |
| Or Eisenberg | Executive Officer | |
| Hagit Binder | Executive Officer | |
| Alon Ben-Noon | Executive Officer, Director | |
| Roy Golan | Director | |
| Ferenc Tracik | Executive Officer |
Every Form D from the week of Dec 9, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NeuroSense Therapeutics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.